Taysha Gene Therapies
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TSHA and other ETFs, options, and stocks.About TSHA
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing.
TSHA Key Statistics
Stock Snapshot
With a market cap of 1.28B, Taysha Gene Therapies(TSHA) trades at $4.66. The stock has a price-to-earnings ratio of -13.15.
As of 2026-01-24, Taysha Gene Therapies(TSHA) stock has fluctuated between $4.63 and $5.04. The current price stands at $4.66, placing the stock +0.6% above today's low and -7.5% off the high.
The Taysha Gene Therapies(TSHA)'s current trading volume is 4.46M, compared to an average daily volume of 2.97M.
In the last year, Taysha Gene Therapies(TSHA) shares hit a 52-week high of $6.02 and a 52-week low of $1.05.
In the last year, Taysha Gene Therapies(TSHA) shares hit a 52-week high of $6.02 and a 52-week low of $1.05.
Analyst ratings
100%
of 14 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.